Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Guacetisal

Copy Product Info
😃Good
Catalog No. T15447Cas No. 55482-89-8

Guacetisal is extracted from the esterification reaction of acetylsalicylic acid with guaiacol which can be used for research on the treatment of chronic bronchitis.

Guacetisal

Guacetisal

Copy Product Info
😃Good
Purity: 99.18%
Catalog No. T15447Cas No. 55482-89-8
Guacetisal is extracted from the esterification reaction of acetylsalicylic acid with guaiacol which can be used for research on the treatment of chronic bronchitis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$38In StockIn Stock
5 mg$58In StockIn Stock
10 mg$106In StockIn Stock
25 mg$196In StockIn Stock
50 mg$250In StockIn Stock
100 mg$352-In Stock
200 mg$492-In Stock
1 mL x 10 mM (in DMSO)$71In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.18%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Guacetisal AI Summary
Guacetisal exhibits a range of bioactivities. It inhibits the human intestinal peptide carrier PEPT1 with a Ki value of 90000.0 nM and shows binding affinity in human Caco-2 cells at the same Ki value. It activates human PEPT1 expressed in MDCK cells with an EC50 of 100000.0 nM and achieves a maximum activation of 102.0% relative to Gly-Sar, with an IC50 of 110000.0 nM. Moreover, Guacetisal demonstrates biological activity against Angiotensin I converting enzyme, with an IC50 value of 457088.19 nM. Additionally, it binds to the human peptide transporter PepT2 in SKTP cells, exhibiting Ki values of 4400.0 nM and 4365.16 nM in different assays, indicating a moderate binding affinity..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Guacetisal is extracted from the esterification reaction of acetylsalicylic acid with guaiacol which can be used for research on the treatment of chronic bronchitis.
Chemical Properties
Molecular Weight286.28
FormulaC16H14O5
Cas No.55482-89-8
SmilesO=C(OC=1C=CC=CC1OC)C=2C=CC=CC2OC(=O)C
Relative Density.1.220 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 95 mg/mL (331.84 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (11.53 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4931 mL17.4654 mL34.9308 mL174.6542 mL
5 mM0.6986 mL3.4931 mL6.9862 mL34.9308 mL
10 mM0.3493 mL1.7465 mL3.4931 mL17.4654 mL
20 mM0.1747 mL0.8733 mL1.7465 mL8.7327 mL
50 mM0.0699 mL0.3493 mL0.6986 mL3.4931 mL
100 mM0.0349 mL0.1747 mL0.3493 mL1.7465 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Guacetisal | purchase Guacetisal | Guacetisal cost | order Guacetisal | Guacetisal chemical structure | Guacetisal formula | Guacetisal molecular weight